Flexion Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare Conference
Rhea-AI Summary
Flexion Therapeutics, Inc. (Nasdaq: FLXN) announced that its CEO, Michael Clayman, M.D., will participate in a virtual fireside chat at the BMO 2020 Prescriptions for Success Healthcare Conference. The event is scheduled for June 23, 2020, starting at 9:30 a.m. ET. Interested parties can access the live webcast on Flexion's website. Flexion Therapeutics focuses on creating innovative local therapies for musculoskeletal conditions, particularly targeting osteoarthritis.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – FLXN
On the day this news was published, FLXN gained 1.18%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
BURLINGTON, Mass., June 16, 2020 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the BMO 2020 Prescriptions for Success Healthcare Conference. The virtual fireside chat is scheduled to begin at 9:30 a.m. ET on Tuesday, June 23, 2020.
To access the live webcast of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com.
About Flexion Therapeutics
Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company's core values are focus, ingenuity, tenacity, transparency and fun. Visit flexiontherapeutics.com.
Contact:
Scott Young
Vice President, Corporate Communications & Investor Relations
Flexion Therapeutics, Inc.
T: 781-305-7194
syoung@flexiontherapeutics.com